SecBot SecBot
COURT-RULING ·Filed May 11, 2026

WRB

BERKLEY W R CORP
BULLISH
Impact 6/10
Horizonmonths Processed5mo ago CourtCourt Ruling · courtlistener.com
Court ruling (appellate)
Actionable Insight ▲ Bullish

This ruling removes a material coverage liability for WRB and reinforces the enforceability of capacity exclusions in D&O policies under New Jersey law. However, the dissent and unresolved factual issues on withholding consent to settle suggest some residual litigation risk on remand for Berkley's unreimbursed defense costs.

DirectionBullish
Confidencehigh
Horizonmonths

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$65.87
T+0 close · May 12, 2026 · via day close
Latest settled
+8.54%
T+60 · $71.50
Vs SPY
+3.52%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · May 12 $65.87entry
  2. T+1 · 6mo ago −1.70%α −2.26% · $64.75
  3. T+5 · 6mo ago +2.94%α +3.55% · $67.81
  4. T+20 · 5mo ago +2.39%α +4.12% · $67.44
  5. T+60 · 3mo ago +8.54%α +3.52% · $71.50
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

The New Jersey Supreme Court ruled that Berkley Insurance Company validly denied coverage to Mist Pharmaceuticals under a D&O policy's capacity exclusion, holding that the claims against Mist Pharmaceuticals solely involved Krivulka's wrongful acts in an uninsured capacity (as a director of Akrimax). The Court affirmed the Appellate Division's reversal of the trial court's $1.75M judgment against Berkley, finding Berkley properly reserved its rights and did not forfeit coverage defenses by withholding consent to settle. This is a clear legal win for Berkley, removing a ~$2.5M liability and confirming that its policy exclusion language is enforceable.

Court Ruling Details

Ruling Date
May 11, 2026
Court
Supreme Court of New Jersey
Court Level
Appellate
Judge
Justice Patterson
Case Type
contract
Ruling Type
final judgment
Outcome
WIN: ruling favors this company
Precedent Risk
LOW

Key Facts

  • New Jersey Supreme Court held that Berkley's D&O capacity exclusion unambiguously bars coverage for Mist Pharmaceuticals' claims because all underlying allegations involved Krivulka's wrongful acts as a director/member of uninsured entities (Akrimax, Mist Acquisition, etc.)
  • Court found Berkley did not forfeit its right to rely on the capacity exclusion; it repeatedly reserved rights in letters and emails at least 10 times over 5 years
  • Court rejected estoppel argument under Griggs v. Bertram, noting Berkley gave timely notice of potential disclaimer unlike the insurer in that case
  • Court distinguished Fireman's Fund Insurance Co. v. Security Insurance Co., finding no bad faith or breach because Berkley correctly determined the policy did not cover the claims
  • Dissent by Justice Fasciale argued Berkley's conduct estopped it from relying on the exclusion and that the exclusion does not bar all coverage when an insured acts in dual capacities

Financial Impact

Eliminates $1.75M judgment against Berkley plus $796K in legal fees; policy limit exposure of $2M removed

liabilitylegal reserves

Risk Factors

  • Dissent raises possibility of remand for factual determinations on whether Berkley unreasonably withheld consent to settle
  • Mist Pharmaceuticals may seek certiorari to U.S. Supreme Court (though unlikely given state-law grounding)
  • Claim of $300M settlement exposure in underlying case could resurface via other theories if coverage ruling is overturned on rehearing

Market Snapshot

Exchange
NYSE
Sector
Fire, Marine & Casualty Insurance
Analyst Consensus
4% bullish (27 analysts)

Investment Themes

Traditional Finance

Documents Analyzed

This report is based on 1 court opinion.

DocumentAccession Number
COURT-RULING Data (Synthetic)court-fbhddsn5-WRB

Track record

11 reports on WRB

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 2, 202614d ago S-3ASR Neutral 2/10 Entry $75.12 to $76.83 Now $78.52 +4.53% ▲ +2.28% +2.86% vs SPY
  2. Oct 30, 202617d ago SC 13G/A Neutral 2/10 Entry $73.86 to $75.23 Now $78.52 +6.31% ▲ +1.85% +4.56% vs SPY
  3. Oct 29, 202618d ago Institutional Cluster Mixed 3/10 Entry $73.10 to $76.98 Now $78.52 +7.41% ▲ +5.31% +10.03% vs SPY
  4. Oct 27, 202620d ago SC 13G/A Neutral 3/10 Entry $71.63 to $76.71 Now $78.52 +9.62% ▲ +7.09% +7.80% vs SPY
  5. Oct 19, 202628d ago 8-K Bearish 6/10 Entry $73.15 to $72.38 Now $78.52 −7.34% ▲ +1.05% +1.13% vs SPY
  6. Jun 26, 202620w ago 8-K Neutral 2/10 Entry $71.01 to $70.92 Now $78.52 +10.58% ▼ −0.13% −1.51% vs SPY
  7. Jun 11, 202622w ago Institutional Cluster Mixed 5/10 Entry $68.27 to $67.18 Now $78.52 +15.01% ▼ −1.60% −2.27% vs SPY
  8. Jun 10, 202622w ago 8-K Neutral 4/10 Entry $15.34 Now $78.52 +411.86% No price data
  9. May 11, 202627w ago Court Ruling Bullish 6/10 Viewing Entry $65.87 to $67.81 Now $78.52 +19.20% ▲ +2.94% +3.55% vs SPY
  10. Apr 21, 202629w ago 8-K Bullish 8/10 No price data
Showing 10 of 11

US Market Status

Market Closed · Opens in 8h 57m

Subscribe to SecBot

Get Real-Time Court Ruling Intelligence

Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
⚖ Court Ruling · courtlistener.com Report published Jun 10, 2026